Myasthenia gravis: open trials in Greece

• NCT07463521

  A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  Trial Treatment · Phase 3 · UCB Biopharma SRL

  Eginitio Hospital, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · General University Hospital of Larissa, Larissa · General University Hospital Of Patras, Patras

  Registry updated 2026-11-06

• NCT07465289

  A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  Trial Treatment · Phase 3 · UCB Biopharma SRL

  Eginitio Hospital, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · General University Hospital of Larissa, Larissa · General University Hospital Of Patras, Patras

  Registry updated 2026-11-06

• NCT07673627

  ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis

  Trial Treatment · Phase 2 · argenx

  Eginitio Hospital, Athens · University General Hospital of Thessaloniki - AHEPA, Thessaloniki

  Registry updated 2026-11-04

• NCT07294170

  ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

  Research · argenx

  Eginitio Hospital, Athens · AHEPA University General Hospital of Thessaloniki, Thessaloniki

  Registry updated 2026-10-26

• NCT06463587

  Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  Trial Treatment · Phase 3 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

  General University Hospital of Larissa, Larissa · General University Hospital Of Patras, Patras · University General Hospital of Thessaloniki - AHEPA, Thessaloniki

  Registry updated 2026-10-21

• NCT07284420

  ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

  Trial Treatment · Phase 2 · argenx

  Eginitio Hospital, Athens · University General Hospital of Thessaloniki - AHEPA, Thessaloniki

  Registry updated 2026-09-24

• NCT07039916

  Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

  Trial Treatment · Phase 3 · Immunovant Sciences GmbH

  Eginitio Hospital, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · General University Hospital Of Patras, Patras · University General Hospital of Thessaloniki - AHEPA, Thessaloniki

  Registry updated 2026-07-30

All Myasthenia gravis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error